{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:43:10Z","timestamp":1791931390424,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/labinvest.2013.98","type":"journal-article","created":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T08:36:27Z","timestamp":1376296587000},"page":"1115-1127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin"],"prefix":"10.1016","volume":"93","author":[{"given":"Wa","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A","family":"Perruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rodriguez-Waitkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladan","family":"Enayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvaneswari","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Edmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo L","family":"Hochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina C","family":"Lev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy L","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2013.98_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI11432","article-title":"Clonality and altered behavior of endothelial cells from hemangiomas","volume":"107","author":"Boye","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2013.98_bib2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm.1877","article-title":"Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma","volume":"14","author":"Jinnin","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2013.98_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jso.20766","article-title":"Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas","volume":"97","author":"Itakura","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1038\/labinvest.2013.98_bib4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/SLA.0b013e3181dbb75a","article-title":"Angiosarcoma: clinical and molecular insights","volume":"251","author":"Lahat","year":"2010","journal-title":"Ann Surg"},{"key":"10.1038\/labinvest.2013.98_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1593\/neo.111770","article-title":"Efficacy of Tie2 receptor antagonism in angiosarcoma","volume":"14","author":"Hasenstein","year":"2012","journal-title":"Neoplasia"},{"key":"10.1038\/labinvest.2013.98_bib6","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/0008-5472.CAN-09-2068","article-title":"KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors","volume":"69","author":"Antonescu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2013.98_bib7","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1158\/0008-5472.CAN-12-0440","article-title":"Ikk4a\/Arf inactivation with activation of the NF-kappaB\/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma","volume":"72","author":"Yang","year":"2012","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2013.98_bib8","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1172\/JCI24726","article-title":"Akt1\/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis","volume":"115","author":"Ackah","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2013.98_bib9","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","article-title":"Mechanism of activation of protein kinase B by insulin and IGF-1","volume":"15","author":"Alessi","year":"1996","journal-title":"EMBO J"},{"key":"10.1038\/labinvest.2013.98_bib10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov dos","year":"2005","journal-title":"Science"},{"key":"10.1038\/labinvest.2013.98_bib11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1126\/science.279.5351.710","article-title":"Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B","volume":"279","author":"Stephens","year":"1998","journal-title":"Science"},{"key":"10.1038\/labinvest.2013.98_bib12","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1101\/gad.995802","article-title":"Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1\/eIF4E","volume":"16","author":"Fingar","year":"2002","journal-title":"Genes Dev"},{"key":"10.1038\/labinvest.2013.98_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/excr.1999.4683","article-title":"Ribosomal S6 kinase signaling and the control of translation","volume":"253","author":"Dufner","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1038\/labinvest.2013.98_bib14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","article-title":"Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1","volume":"11","author":"Guertin","year":"2006","journal-title":"Dev Cell"},{"key":"10.1038\/labinvest.2013.98_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BJ20081668","article-title":"mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)","volume":"416","author":"Garcia-Martinez","year":"2008","journal-title":"Biochem J"},{"key":"10.1038\/labinvest.2013.98_bib16","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1073\/pnas.0510857103","article-title":"Cancer-specific mutations in PIK3CA are oncogenic in vivo","volume":"103","author":"Bader","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/labinvest.2013.98_bib17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi's sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/labinvest.2013.98_bib18","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1002\/cncr.27614","article-title":"Alterations of the p53 and PIK3CA\/AKT\/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics","volume":"118","author":"Italiano","year":"2012","journal-title":"Cancer"},{"key":"10.1038\/labinvest.2013.98_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0024-3205(95)02233-3","article-title":"Mechanism of action of the immunosuppressant rapamycin","volume":"58","author":"Dumont","year":"1996","journal-title":"Life Sci"},{"key":"10.1038\/labinvest.2013.98_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ccr.2006.07.003","article-title":"Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin","volume":"10","author":"Phung","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1038\/labinvest.2013.98_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2013.98_bib22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/156800909788166556","article-title":"The applicability of mTOR inhibition in solid tumors","volume":"9","author":"Konings","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1038\/labinvest.2013.98_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","article-title":"Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial","volume":"372","author":"Motzer","year":"2008","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1038\/labinvest.2013.98_bib24","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1053\/j.seminoncol.2009.10.010","article-title":"Evaluating temsirolimus activity in multiple tumors: a review of clinical trials","volume":"36","author":"Dancey","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1038\/labinvest.2013.98_bib25","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ejca.2011.02.017","article-title":"A phase I study of sirolimus and bevacizumab in patients with advanced malignancies","volume":"47","author":"Cohen","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1038\/labinvest.2013.98_bib26","doi-asserted-by":"crossref","first-page":"e42913","DOI":"10.1371\/journal.pone.0042913","article-title":"Rapamycin inhibits proliferation of hemangioma endothelial cells by reducing HIF-1-dependent expression of VEGF","volume":"7","author":"Medici","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/labinvest.2013.98_bib27","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/jid.2011.300","article-title":"Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma","volume":"131","author":"Greenberger","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.2013.98_bib28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1038\/labinvest.2013.98_bib29","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1038\/labinvest.2013.98_bib30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2133.2011.10471.x","article-title":"A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity","volume":"165","author":"Wataya-Kaneda","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1038\/labinvest.2013.98_bib31","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1468-3083.2011.04212.x","article-title":"Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis\u2014associated facial angiofibroma","volume":"26","author":"Salido","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1038\/labinvest.2013.98_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.1998.3936","article-title":"A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells","volume":"240","author":"Richard","year":"1998","journal-title":"Exp Cell Res"},{"key":"10.1038\/labinvest.2013.98_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/10623320390272316","article-title":"Establishment and characterization of an angiosarcoma-derived cell line, AS-M","volume":"10","author":"Krump-Konvalinkova","year":"2003","journal-title":"Endothelium"},{"key":"10.1038\/labinvest.2013.98_bib34","first-page":"259","article-title":"A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology","volume":"63","author":"Obeso","year":"1990","journal-title":"Lab Invest"},{"key":"10.1038\/labinvest.2013.98_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0092-8674(90)90009-4","article-title":"Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene","volume":"62","author":"Montesano","year":"1990","journal-title":"Cell"},{"key":"10.1038\/labinvest.2013.98_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/modpathol.3880014","article-title":"A novel in vitro human model of hemangioma","volume":"13","author":"Tan","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1038\/labinvest.2013.98_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1038\/labinvest.2013.98_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0046-8177(00)80192-6","article-title":"GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas","volume":"31","author":"North","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1038\/labinvest.2013.98_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/PAS.0b013e3180f633a3","article-title":"Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69 cases","volume":"32","author":"Deyrup","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/labinvest.2013.98_bib40","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1101\/gad.912401","article-title":"Hierarchical phosphorylation of the translation inhibitor 4E-BP1","volume":"15","author":"Gingras","year":"2001","journal-title":"Genes Dev"},{"key":"10.1038\/labinvest.2013.98_bib41","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O'Reilly","year":"2006","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2013.98_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1158\/2159-8290.CD-11-0085","article-title":"mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling","volume":"1","author":"Rodrik-Outmezguine","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1038\/labinvest.2013.98_bib43","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/labinvest.2013.98_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov dos","year":"2006","journal-title":"Mol Cell"},{"key":"10.1038\/labinvest.2013.98_bib45","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1158\/0008-5472.CAN-06-3341","article-title":"Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression","volume":"67","author":"Phung","year":"2007","journal-title":"Cancer Res"},{"issue":"Suppl B","key":"10.1038\/labinvest.2013.98_bib46","doi-asserted-by":"crossref","first-page":"B93","DOI":"10.1016\/S0149-2918(00)89026-8","article-title":"Toxicity and efficacy of sirolimus: relationship to whole-blood concentrations","volume":"22","author":"Meier-Kriesche","year":"2000","journal-title":"Clin Ther"},{"key":"10.1038\/labinvest.2013.98_bib47","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.1074\/jbc.M700906200","article-title":"RAS\/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation","volume":"282","author":"Roux","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2013.98_bib48","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/mend.14.6.0446","article-title":"A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1","volume":"14","author":"Haruta","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1038\/labinvest.2013.98_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"Chandarlapaty","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1038\/labinvest.2013.98_bib50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/SAP.0b013e318216b4f8","article-title":"Novel strategies for managing infantile hemangiomas: a review","volume":"68","author":"Azzopardi","year":"2012","journal-title":"Ann Plast Surg"},{"key":"10.1038\/labinvest.2013.98_bib51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.otc.2012.03.001","article-title":"Current management of infantile hemangiomas and their common associated conditions","volume":"45","author":"Hartzell","year":"2012","journal-title":"Otolaryngol Clin N Am"},{"key":"10.1038\/labinvest.2013.98_bib52","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00130404-200505000-00011","article-title":"A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy","volume":"11","author":"Fury","year":"2005","journal-title":"Cancer J"},{"key":"10.1038\/labinvest.2013.98_bib53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/hed.20674","article-title":"Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies","volume":"30","author":"Koontz","year":"2008","journal-title":"Head Neck"},{"key":"10.1038\/labinvest.2013.98_bib54","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1245\/s10434-006-9335-y","article-title":"Treatment and outcome of 82 patients with angiosarcoma","volume":"14","author":"Abraham","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1038\/labinvest.2013.98_bib55","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1200\/JCO.2008.17.3146","article-title":"Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study","volume":"26","author":"Penel","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest201398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201398","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722008911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722008911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201398.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:32:28Z","timestamp":1758396748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722008911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0023683722008911"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2013.98","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2013.98","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2013.109","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}